MedTrace Logo

Dexamethasone and Induction of Delivery

NCT03658590 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2018-09-05

No results posted yet for this study

Summary

This study aims to evaluate the effect of intravenous injection of a single dose of dexamethasone in shortening the duration interval between initiation of labor induction and delivery of the fetus in primigravida full-term pregnancy.

Conditions

  • Induction of Labor Affected Fetus / Newborn

Interventions

DRUG

Dexamethasone

a prefilled syringe with two milliliters (8 mg) of dexamethasone intravenously

DRUG

Distilled Water

a prefilled syringe with two milliliters of distilled water intravenously.

Sponsors & Collaborators

  • samar sayed el sayed

    lead OTHER

Principal Investigators

  • Tarek F Tamara, MD · Ain Shams University

  • Amgad E Abou Gamrah, MD · Ain Shams University

  • Gihan E Elhawwary, MD · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-04-15
Completion
2018-06-30
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03658590 on ClinicalTrials.gov